GovChime
UEI: M9V9QTHR1H28 • CAGE: 417U0

MAPP BIOPHARMACEUTICAL, INC. (CA)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2012
$667.89M
$667,889,247under this UEI
FY2026 obligations
$83.12M
$83,118,298Provisional
Awards and orders
21
with positive net obligations2 IDV vehicles held
Latest action
Sep 30, 2026
SAM.gov registration
Active
Registration expiration date Mar 20, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Jul 9, 2003 (23 years)
Location
San Diego, CA
State of incorporation
Delaware

† FY2026 obligations (provisional; DoD awards signed after Jul 27, 2026 are not yet public).

Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 27, 2026 are not yet public.

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI M9V9QTHR1H28. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2012. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2026: $83,118,298 (provisional)
  • FY2025: $48,110,334
  • FY2024: $2,971,390
  • FY2023: $61,565,435
  • FY2022: $224,322,780
  • FY2021: -$29,763,711 (de-obligation)
  • FY2020: $24,686,822
  • FY2019: $25,603,515
Show all 15 years
  • FY2018: $93,531,231
  • FY2017: $52,687,364
  • FY2016: $22,069,589
  • FY2015: $23,178,046
  • FY2014: $33,388,787
  • FY2013: $2,330,826
  • FY2012: $88,540

Total across 15 fiscal years: $667,889,247

Net de-obligation in that fiscal year (obligations withdrawn).

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • AN13Health r&d services; health care services; experimental development$257,516,622, 38.6%
  • 6505Drugs and biologicals$237,329,325, 35.5%
  • AN12R&d- medical: biomedical (applied research/exploratory development)$98,737,298, 14.8%
  • AN11R&d- medical: biomedical (basic research)$65,758,722, 9.8%
  • AJ11General science and technology r&d services; general science and technology; basic research$6,776,777, 1.0%

Capabilities

NAICS codes

Small: small business for that NAICS, self-certified in SAM.gov registration.

SBA certifications

No certification in the SBA profile data.

Federal Capability Statement

monoclonal antibody drug development; anti-infectives

Capabilities & Services

monoclonal antibodies
therapeutics
anti-infectives

Contracts

Latest awards and orders

  1. HHSO100201600021CDefinitive contractDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action
  2. 75A50124C00003Definitive contractDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action
  3. 75A50122C00061Definitive contractDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action
  4. 75A50122C00076Definitive contractDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action
  5. HT942626FE075Delivery orderunder an indefinite delivery contract (IDC)Department of DefenseDefense Health AgencyLatest action
  6. HT942525D0009Indefinite delivery contract (IDC)VehicleDepartment of DefenseDefense Health AgencyLatest action
  7. 75A50118C00024Definitive contractDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseLatest action
  8. 75A50119D00018Indefinite delivery contract (IDC)VehicleDepartment of Health and Human ServicesAdministration for Strategic Preparedness and ResponseLatest action
  9. HHSO100201700023CDefinitive contractDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseLatest action
  10. 75A50120C00198Definitive contractDepartment of Health and Human ServicesOffice of Assistant Secretary for Preparedness and ResponseLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for MAPP BIOPHARMACEUTICAL, INC. lists a physical address and a separate mailing address, along with 5 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

4921 DIRECTORS PL

STE 100

SAN DIEGO, CA, 92121

USA

Mailing Address

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Government Business Contact

LARRY ZEITLIN

MAPP BIOPHARMACEUTICAL, INC.

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Electronic Business Contact

LARRY ZEITLIN

MAPP BIOPHARMACEUTICAL, INC.

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Past Performance Contact

LARRY ZEITLIN

MAPP BIOPHARMACEUTICAL, INC.

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Government Business Alternate Contact

LARRY ZEITLIN

MAPP BIOPHARMACEUTICAL, INC.

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Electronic Business Alternate Contact

LARRY ZEITLIN

MAPP BIOPHARMACEUTICAL, INC.

4921 DIRECTORS PL STE 100

SAN DIEGO, CA, 92121

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

MAPP BIOPHARMACEUTICAL, INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires March 20, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Subchapter S Corporation

Registration Details

Source: SAM.gov

Initial Registration

Jul 19, 2005

Last Update

Mar 24, 2026

Registration Activation

Active — Mar 24, 2026

Fiscal Year End

1231

Country of Incorporation

USA

Congressional District

51